WHO Sounds Concern Over Acute Scarcity of Weight-Loss Jabs

Less than 10% of people who could benefit from weight-loss injections such as Wegovy are able to get them, warns the World Health Organization as it issues its initial guidance on the medications.

Considering more than one billion individuals worldwide currently classified as obese, it is advocating for broader and more equitable availability to these injectable treatments.

According to forecasts, more than two billion will be living with obesity by 2030 if no action is taken.

"The new guidance recognises that excess weight is a long-term condition that can be managed with thorough and ongoing support," remarked the agency's head Tedros Adhanom Ghebreyesus.

High costs, constrained manufacturing, and logistical bottlenecks are key barriers to widespread availability to the jabs that can assist patients in reducing significant weight, says the organization.

Skinny Jab Scarcity

Even under the present best projected outlook, the manufacturing of such drugs might only reach around 100 million people – fewer than 10% of the global need, according to the WHO.

The recommendation urges countries and companies to expand availability, through strategies like patent sharing.

The intellectual property rights on the active ingredient – the primary ingredient of Novo Nordisk's Wegovy – is scheduled to end in multiple countries in 2026.

How Obesity Jabs Work

The injections imitate a natural hormone to delay gastric emptying, curb appetite and enhance satiety so individuals consume fewer calories.

Patients usually start to lose weight after several weeks of starting on the weekly injections.

Studies points to people may regain a significant portion a year later of halting the medication, when their usual food cravings come back.

Being carrying excess weight raises your chance for experiencing health problems, including diabetes, cardiovascular issues, brain attack, and some malignancies.

Obesity affects people in all nations and was responsible for over three and a half million fatalities worldwide in 2024, per the WHO.

James Parker
James Parker

A travel writer and urban explorer documenting city cultures and sustainable living practices across global metropolises.